Genes, proteins, and neurotoxins involved in Parkinson's disease

被引:141
作者
von Bohlen und Halbach, O
Schober, A
Krieglstein, K
机构
[1] Heidelberg Univ, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany
[2] Univ Gottingen, Dept Neuroanat, D-37075 Gottingen, Germany
[3] Univ Gottingen, Dept Neuroanat, CMPB, D-37075 Gottingen, Germany
关键词
D O I
10.1016/j.pneurobio.2004.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder. The etiology of PD is likely due to combinations of environmental and genetic factors. In addition to the loss of neurons, including dopaminergic neurons in the substantia nigra pars compacta, a further morphologic hallmark of PD is the presence of Lewy bodies and Lewy neurites. The formation of these proteinaceous inclusions involves interaction of several proteins, including alpha-synuclein, synphilin-1, parkin and UCH-L1. Animal models allow to get insight into the mechanisms of several symptoms of PD, allow investigating new therapeutic strategies and, in addition, provide an indispensable tool for basic research. In animals PD does not arise spontaneously, thus, characteristic and specific functional changes have to be mimicked by application of neurotoxic agents or by genetic manipulations. In this review we will focus on genes and gene loci involved in PD, the functions of proteins involved in the formation of cytoplasmatic inclusions, their interactions, and their possible role in PD. In addition, we will review the current animal models of PD. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:151 / 177
页数:27
相关论文
共 307 条
[51]   Where does Parkinson disease pathology begin in the brain? [J].
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Bohl, JRE ;
Braak, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05) :413-426
[52]   Part I: Parkin-associated proteins and Parkinson's disease [J].
Dev, KK ;
van der Putten, H ;
Sommer, B ;
Rovelli, G .
NEUROPHARMACOLOGY, 2003, 45 (01) :1-13
[53]   INCREASED LEVELS OF LIPID HYDROPEROXIDES IN THE PARKINSONIAN SUBSTANTIA-NIGRA - AN HPLC AND ESR STUDY [J].
DEXTER, DT ;
HOLLEY, AE ;
FLITTER, WD ;
SLATER, TF ;
WELLS, FR ;
DANIEL, SE ;
LEES, AJ ;
JENNER, P ;
MARSDEN, CD .
MOVEMENT DISORDERS, 1994, 9 (01) :92-97
[54]   INDEXES OF OXIDATIVE STRESS AND MITOCHONDRIAL-FUNCTION IN INDIVIDUALS WITH INCIDENTAL LEWY BODY DISEASE [J].
DEXTER, DT ;
SIAN, J ;
ROSE, S ;
HINDMARSH, JG ;
MANN, VM ;
COOPER, JM ;
WELLS, FR ;
DANIEL, SE ;
LEES, AJ ;
SCHAPIRA, AHV ;
JENNER, P ;
MARSEN, CD .
ANNALS OF NEUROLOGY, 1994, 35 (01) :38-44
[55]   GLUTAMATE RECEPTORS IN THE SUBSTANTIA-NIGRA OF PARKINSONS-DISEASE BRAINS [J].
DIFAZIO, MC ;
HOLLINGSWORTH, Z ;
YOUNG, AB ;
PENNEY, JB .
NEUROLOGY, 1992, 42 (02) :402-406
[56]  
Djaldetti Ruth, 2002, Journal of Neurology, V249, P30
[57]   Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1 [J].
Dong, ZZ ;
Ferger, B ;
Paterna, JC ;
Vogel, D ;
Furler, S ;
Osinde, M ;
Feldon, J ;
Büeler, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12438-12443
[58]   Prospects for new restorative and neuroprotective treatments in Parkinson's disease [J].
Dunnett, SB ;
Björklund, A .
NATURE, 1999, 399 (6738) :A32-A39
[59]   S18Y polymorphism in the UCH-L1 gene and Parkinson's disease:: Evidence for an age-dependent relationship [J].
Elbaz, A ;
Levecque, C ;
Clavel, J ;
Vidal, JS ;
Richard, F ;
Corrèze, JR ;
Delemotte, B ;
Amouyel, P ;
Alpérovitch, A ;
Chartier-Harlin, MC ;
Tzourio, C .
MOVEMENT DISORDERS, 2003, 18 (02) :130-137
[60]   Conformational properties of α-synuclein in its free and lipid-associated states [J].
Eliezer, D ;
Kutluay, E ;
Bussell, R ;
Browne, G .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (04) :1061-1073